Stockscreener 앱 받기
40.72
0.83%
0.335
Crispr Therapeutics Ag (CRSP) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
99.75%
0.504
|
201.21 | - | 70.00 | 100.00 |
Operating Expenses
|
7.19%
141.09
|
131.62 | 132.41 | 165.22 | 164.49 |
| Benefits Costs and Expenses |
4.25%
116.37
|
111.63 | 111.74 | 146.82 | 151.75 |
| Costs And Expenses |
4.25%
116.37
|
111.63 | 111.74 | 146.82 | 151.75 |
| Operating Income/Loss |
302.04%
-140.59
|
69.58 | -132.41 | -95.22 | -64.49 |
| Nonoperating Income/Loss |
23.62%
24.72
|
20.00 | 20.67 | 18.41 | 12.74 |
| Income/Loss From Continuing Operations Before Tax |
229.34%
-115.87
|
89.58 | -111.74 | -76.82 | -51.74 |
| Income Tax Expense/Benefit |
210.73%
0.724
|
0.233 | 0.412 | 0.923 | 1.32 |
| Income/Loss From Continuing Operations After Tax |
230.49%
-116.59
|
89.35 | -112.15 | -77.74 | -53.06 |
|
Net Income/Loss
|
230.49%
-116.59
|
89.35 | -112.15 | -77.74 | -53.06 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
51,828%
81.79
|
0.1575 | 79.41 | 79.09 | 78.68 |
| Diluted Average Shares |
51,828%
81.79
|
0.1575 | 79.41 | 79.09 | 78.68 |
| Basic Earnings Per Share |
226.55%
-1.43
|
1.13 | -1.41 | -0.98 | -0.67 |
| Diluted Earnings Per Share |
226.55%
-1.43
|
1.13 | -1.41 | -0.98 | -0.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
자본화:
|
볼륨(24시간):